Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

While sometimes thought of solely as protein building blocks, AAs are master regulators acting at the intersection of diverse pathways ... metabolic dysregulation is the underlying driver of liver ...

N-terminal kinase exerts a cross-tissue therapeutic effect on metabolic dysfunction induced by sucrose overconsumption in rats.

"The glycolytic enzyme aldolase is essential for liver cancer cells, although the glycolytic pathway itself is apparently dispensable," says metabolism expert Schulze, summarizing the findings.

Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic-associated fatty liver disease, a new study in mice suggests.

Patients with celiac disease who had concurrent autoimmune or metabolic-related diseases had further heightened risks. "The absolute risk difference for any chronic liver disease between patients ...